IMARC Group has recently released a new research study titled “Mexico Catheters Market Size, Share, Trends and Forecast by Product Type, End User, and Region, 2026-2034” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

Market Overview

The Mexico catheters market size was valued at USD 381.74 Million in 2025 and is projected to reach USD 681.58 Million by 2034, growing at a compound annual growth rate (CAGR) of 6.65% from 2026 to 2034. This growth is driven by an aging population and rising prevalence of cardiovascular diseases, diabetes, and chronic kidney conditions, alongside healthcare modernization and increased government investment. The market preference for minimally invasive catheter-based procedures enhances demand across multiple therapeutic areas.

Study Assumption Years

  • Base Year: 2025
  • Historical Year/Period: 2020-2025
  • Forecast Year/Period: 2026-2034

Mexico Catheters Market Key Takeaways

  • Current Market Size: USD 381.74 Million in 2025
  • CAGR: 6.65% from 2026-2034
  • Forecast Period: 2026-2034
  • Cardiovascular catheters dominate with a 28% market share in 2025, driven by the high burden of heart disease.
  • Hospitals and clinics lead the end user segment with a 71% market share in 2025.
  • The market is led by a mix of multinational corporations and regional distributors leveraging extensive networks.
  • Government investments in healthcare infrastructure, including inauguration of new hospitals and clinics in 2025, support market growth.
  • Mexico’s growing reputation as a medical tourism hub is boosting demand for advanced catheter products.

Sample Request Link: https://www.imarcgroup.com/mexico-catheters-market/requestsample

To get more information on this market,  Request Sample

Mexico Catheters Market Growth Factors

Rising Prevalence of Cardiovascular Diseases and Chronic Conditions

Mexico faces a significant burden of cardiovascular diseases, accounting for nearly one-quarter of all deaths. In 2024, approximately 192,518 deaths were attributed to cardiovascular diseases, positioning them as the country's leading cause of mortality. The widespread presence of hypertension (about 29.4% of adults) and diabetes contributes to this demand. Hospitals are expanding catheterization labs to manage increasing patient volumes, supporting minimally invasive diagnostic and therapeutic interventions. These investments facilitate timely diagnosis and long-term management, maintaining significant demand for catheter products.

Government Investments in Healthcare Infrastructure Expansion

The Mexican government is actively increasing healthcare capacity by building new hospitals, modernizing older facilities, and upgrading surgical departments to accommodate advanced treatments. Public institutions like IMSS play a central role in this expansion, broadening access to specialized care regions-wide. In 2025, the opening of 31 new hospitals and 12 primary-care clinics has enhanced healthcare infrastructure and stimulated catheter adoption. These initiatives enable advanced catheter procedures in underserved areas, fostering wider integration of modern medical devices into clinical practice.

Demographic Shifts and Aging Population Dynamics

With lower birth rates and increased life expectancy, Mexico’s aging population reached about 9.68% of those aged 65 and over in 2024—a historic peak. Older adults require greater medical care due to higher prevalence of cardiovascular diseases, urinary complications, and chronic conditions. Healthcare providers are adapting care models for elderly patients needing regular monitoring and minimally invasive interventions. This demographic change is a key driver of rising catheter utilization across Mexico.

Mexico Catheters Market Segmentation

Product Type Insights:

  • Cardiovascular Catheters: Lead the market with 28% share in 2025, essential for diagnostic and therapeutic heart procedures amid high cardiovascular disease prevalence.
  • Urology Catheters
  • Intravenous Catheters
  • Neurovascular Catheters
  • Specialty Catheters
  • Others

End User Insights:

  • Hospitals and Clinics: Dominant end user with 71% market share in 2025; equipped with infrastructure, catheterization labs, and specialized personnel for complex procedures.
  • Ambulatory Surgical Centers
  • Others

Regional Insights:

  • Northern Mexico: Significant market due to advanced healthcare infrastructure in industrial and border cities like Monterrey and Tijuana, with influence from US practices and medical tourism.
  • Central Mexico: Anchored by Mexico City, hosting major hospitals and advanced interventional cardiology programs, leading to high demand for sophisticated catheter technologies.
  • Southern Mexico: Emerging growth area with less-developed healthcare infrastructure; government initiatives are expanding access and upgrading facilities.
  • Others: Include healthcare system developments and regional medical centers benefiting from federal infrastructure programs.

Regional Insights

Northern Mexico is a leading region in the catheters market, benefiting from advanced healthcare infrastructures located in industrial border cities such as Monterrey and Tijuana. Its proximity to the United States encourages adoption of medical practices and supports a burgeoning medical tourism sector attracting patients for catheter-based procedures. This region’s well-developed hospital networks underpin significant market demand.

Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=33402&flag=C

Recent Developments & News

In May 2025, Quasar Medical acquired Nordson MEDICAL’s design and development business, including the Tecate, Mexico facility. This acquisition expanded Quasar’s global CDMO capabilities, strengthening its catheter and interventional device manufacturing by leveraging Nordson MEDICAL’s expertise. Subsequently, in September 2025, Nordson Corporation confirmed divesting its contract-manufacturing design and development units to Quasar Medical, allowing Nordson MEDICAL to focus on proprietary medical components while bolstering Quasar's CDMO position.

Key Players

  • Quasar Medical
  • Nordson MEDICAL
  • Nordson Corporation

Customization Note:

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302